Article
Alpha-Chymotrypsin Protects Against Acute Lung, Kidney, and Liver Injuries and Increases…
Drug Design, Development and Therapy · 2022 · Senousy SR, Ahmed ASF, Abdelhafeez DA, Khalifa MMA, Abourehab MAS, El-Daly M
Key facts
| Title | Alpha-Chymotrypsin Protects Against Acute Lung, Kidney, and Liver Injuries and Increases Survival in CLP-Induced Sepsis in Rats Through Inhibition of TLR4/NF-κB Pathway |
|---|---|
| First author | Senousy SR, Ahmed ASF, Abdelhafeez DA, Khalifa MMA, Abourehab MAS, El-Daly M |
| Journal | Drug Design, Development and Therapy |
| Published | Sep 8, 2022 |
| DOI | 10.2147/DDDT.S370460 |
| Devices mentioned | K071580, K843077, K843710 |
| Product codes mentioned | CIT, DGC, LGC |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1